Login / Signup

Biomarkers for differentiating grade II meningiomas from grade I: a systematic review.

Agbolahan A SofelaLucy McGavinPeter C WhitfieldC Oliver Hanemann
Published in: British journal of neurosurgery (2021)
Being able to predict meningioma grade at presentation using the radiological and blood markers described may influence management as the likely grade II tumours will be followed up or treated more aggressively, while the histological markers may prognosticate progression or post-treatment recurrence. This to an extent offers a more personalised treatment approach for patients.
Keyphrases
  • newly diagnosed
  • prognostic factors
  • magnetic resonance
  • combination therapy
  • replacement therapy
  • contrast enhanced
  • optical coherence tomography
  • smoking cessation